Journal details
MOLECULAR THERAPY
CELL PRESS · ISSN 1525-0016 · eISSN 1525-0024
SCIEScopusMEDLINEPubMedPMC
Overview
MOLECULAR THERAPY is a Biotechnology & Applied Microbiology · Genetics & Heredity · Medicine, Research & Experimental journal published by CELL PRESS (United States). Use this page to check its impact factor, JCR quartile, CAS zone and indexing before you submit. Always confirm the scope, APC and policies on the journal's official website.
Publication output
2026: 250 articles · 2025: 607 articles · 2024: 436 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of MOLECULAR THERAPY?
The impact factor recorded for MOLECULAR THERAPY is 11.4 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of MOLECULAR THERAPY?
MOLECULAR THERAPY is listed in CAS Zone 1 and marked as a TOP journal.
Which databases index MOLECULAR THERAPY?
MOLECULAR THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.